|
|
Volumn 4, Issue 10, 2005, Pages 800-803
|
|
News feature: Painful lessons
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
CELECOXIB;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
NAPROXEN;
NATALIZUMAB;
NON PRESCRIPTION DRUG;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
ROFECOXIB;
TROGLITAZONE;
VALDECOXIB;
PROSTAGLANDIN SYNTHASE INHIBITOR;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
COLON CANCER;
DRUG EFFICACY;
DRUG FATALITY;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG PACKAGING;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG WITHDRAWAL;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL HEMORRHAGE;
HEART ARRHYTHMIA;
HEART INFARCTION;
HUMAN;
LIVER FAILURE;
NOTE;
OSTEOARTHRITIS;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RHABDOMYOLYSIS;
RHEUMATOID ARTHRITIS;
RISK BENEFIT ANALYSIS;
SIDE EFFECT;
SKIN DEFECT;
STROKE;
THROMBOSIS;
ARTHRITIS;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG APPROVAL;
ECONOMICS;
LEGAL ASPECT;
METHODOLOGY;
MORTALITY;
PATHOPHYSIOLOGY;
POSTMARKETING SURVEILLANCE;
RISK;
STATISTICS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
CYCLOOXYGENASE INHIBITORS;
DRUG APPROVAL;
DRUG INDUSTRY;
HUMANS;
PRODUCT SURVEILLANCE, POSTMARKETING;
RISK;
|
|
EID: 27644436865
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd1871 Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|